Paper

Graefes Arch Clin Exp Ophthalmol., April 2010
Rosentreter A, Mellein AC, Konen WW, Dietlein TS. (2010): Capsule excision and Ologen implantation for revision after glaucoma drainage device surgery. Graefes Arch Clin Exp Ophthalmol., 2010 Apr 20. [Epub ahead of print]

Glaucoma Today, February 2010
Steven R. Sarkisian (2010): A REPLACEMENT FOR ANTIMETABOLITES? Ologen is a new product that modulates wound healing in glaucoma surgery. Glaucoma Today.,8:22-24

Updated Publication List, August 2010
Academic journal publications & Presented abstracts/ posters in Ophthalmology congress meetings

Acta Ophthalmologica, February 2010
Papaconstantinou, D., Georgalas, I., Karmiris, E., Diagourtas, A., Koutsandrea, C., Ladas, I., Apostolopoulos, M., and Georgopoulos, G. (2010): Trabeculectomy with ologen versus trabeculectomy for the treatment of glaucoma: a pilot study. Acta Ophthalmol., 88: 80‐85. NOTE: OculusGen™ Collagen Matrix has been renamed into ologen™ Collagen Matrix in July 2007. The implants used in this study are Oculusgen™ Collagen Matrix. The material constituents and the physical properties of OculusGen™ Collagen Matrix has been improved and upgraded for better performance and efficacy. This becomes ologen™ Collagen Matrix. Furthermore, when ologen™ Collagen Matrix is applied in trabeculectomy, loose suture on the sclera flap is strongly recommended.

Doctor Presentation

ologen collagen matrix in strabismus by Dr. Emilio C. Campos, Italy, December 2009
33rd meeting of the European strabismological Association. 4-7 October 2009. Belgrade, Serbia. Ophthalmic Clinic University of Bologna, Italy

Paper

Expert Rev. Ophthalmol., October 2009
Rao, K., Ahmed, I., Blake, D.A., and Ayyala, R.S. (2009): New devices in glaucoma surgery. Expert Rev. Ophthalmol., 4: 491‐504. NOTE: In this review, all the references cited under iGEN™ collagen implant were originally referred to ologen™ Collagen Matrix. The authors of this review and the publisher of the journal have been asked to issue an erratum in order not to misleading the readers.

European Journal of Ophthalmology, March 2009
Aptel, F., Dumas, S., and Denis, P. (2009): Ultrasound biomicroscopy and optical coherence tomography imaging of filtering blebs after deep sclerectomy with new collagen implant. Eur. J. Ophthalmol., 19: 223‐230

Graefes Arch Clin Exp Ophthalmol., December 2008
Dietlein, T.S., Jordan, J., Lueke, C., and Krieglstein, G.K. (2008): Modern concepts in antiglaucomatous implant surgery. Graefes Arch. Clin. Exp. Ophthalmol., 246: 1653‐1664.

Expert Rev. Ophthalmol., December 2008
Zelefsky, J.R., Hsu, W.C., and Ritch, R. (2008): Biodegradable collagen matrix implant for trabeculectomy. Expert Rev. Ophthalmol., 3: 613‐617. Note : OculusGen™ brand has been changed to ologen™ since 2008 and marketed by Aeon Astron Europe B.V.

Animal Study

Invest Ophthalmol Vis Sci., August 2000
Hsu, W.C., Spilker, M.H., Yannas, I.V., Rubin, P.A. (2000): Inhibition of Conjunctival Scarring and Contraction by a Porous Collagen-Glycosaminoglycan Implant. Invest Ophthalmol Vis Sci., 41: 2404-2411.